| Catalogue Number |
Products |
CAS No. |
Assay |
| RovathinS26691 | 4-Amino-2-(methylthio)pyrimidine | 2183-66-6 | 95% |
| RovathinS26692 | 4-(chloromethyl)-1H-pyrazole hydrochloride | 163008-98-8 | 95% |
| RovathinS26693 | Methyl 2-(5-bromo-2-hydroxyphenyl) acetate | 220801-66-1 | 95% |
| RovathinS26694 | 2-Bromo-4'-(trifluoromethoxy)acetophenone | 103962-10-3 | 95% |
| RovathinS26695 | Biphenyl | 92-52-4 | 95% |
| RovathinS26696 | 6-Methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine | 7496-50-6 | 95% |
| RovathinS26697 | Ethyl 2-(benzylamino)propanoate | 54159-18-1 | 95% |
| RovathinS26698 | 4-Bromopyridine | 1120-87-2 | 95% |
| RovathinS26699 | 5-Bromo-2,4-difluorobenzenesulfonyl chloride | 287172-61-6 | 95% |
| RovathinS26700 | 1-Bromo-3-methyl-5-nitrobenzene | 52488-28-5 | 95% |
| RovathinS26701 | 2,4-Bis(Trifluoromethyl)Benzaldehyde | 59664-42-5 | 95% |
| RovathinS26702 | methyl 3-hydroxy-4-methoxybenzenecarboxylate | 6702-50-7 | 95% |
| RovathinS26703 | Methyl (4S,5R)-2,2,5-trimethyl-1,3-dioxolane-4-carboxylate | 38410-80-9 | 95% |
| RovathinS26704 | Olah's reagent | 32001-55-1 | 95% |
| RovathinS26705 | Bifendate | 73536-69-3 | 95% |
| RovathinS26706 | 1-(4-(4-bromophenoxy)phenyl)ethanone | 54916-27-7 | 95% |
| RovathinS26707 | N-Boc-DL-2-phenylglycinol | 67341-01-9 | 95% |
| RovathinS26708 | Dapoxetine hydrochloride | 129938-20-1 | 95% |
| RovathinS26709 | 1H-Pyrrole-3-carboxylic acid, 2,5-dihydro-4-hydroxy-5-oxo-1-phenyl-, ethyl ester | 57056-57-2 | 95% |
| RovathinS26710 | 3-Ethyl-2-benzimidazolinone | 10045-45-1 | 95% |
| RovathinS26711 | 6,7-Dinitro-2,3-dihydroxyquinoxaline | 2379-57-9 | 95% |
| RovathinS26712 | [1,1'-Biphenyl]-4-carboxamide, 2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[3-(4-methyl-1-piperazinyl)-4-[(methylsulfonyl)oxy]phenyl]- | 256227-78-8 | 95% |
| RovathinS26713 | [1,1'-Biphenyl]-4-carboxamide, N-[4-hydroxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)- | 256227-77-7 | 95% |
| RovathinS26714 | [1,1'-Biphenyl]-4-carboxamide, N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)- | 148672-15-5 | 95% |
| RovathinS26715 | Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)-, dihydrochloride | 67469-75-4 | 95% |
| RovathinS26716 | Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)- | 67469-57-2 | 95% |
| RovathinS26717 | 1-(Aminomethyl)cyclohexaneacetic acid | 60142-96-3 | 95% |
| RovathinS26718 | N-[3-[[2-(4-Aminofurazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[[2-(4-morpholinyl)ethyl]oxy]benzamide | 850664-21-0 | 95% |
| RovathinS26719 | [1,1'-Biphenyl]-4,4'-dicarboxamide, N4'-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2-methyl- | 691846-63-6 | 95% |
| RovathinS26720 | 2-Thiophenecarboxamide, 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]- | 660868-91-7 | 95% |
Product Search
